'Guardant Health (GH) is our top growth idea'; PT Lowered to $120 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Dan Brennan lowered the price target on Guardant Health (NASDAQ: GH) to $120.00 (from $135.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
